Guardant Health
GH
#1353
Rank
C$23.18 B
Marketcap
C$174.87
Share price
5.47%
Change (1 day)
223.27%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

P/S ratio for Guardant Health (GH)

P/S ratio as of May 2026 (TTM): 15.6

According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -170. At the end of 2026 the company had a P/S ratio of 10.3.

P/S ratio history for Guardant Health from 2018 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202610.3-23.64%
202513.5164.39%
20245.09-12.59%
20235.82-6.07%
20226.20-77.22%
202127.2-39.44%
202044.931.28%
201934.2-3.75%
201835.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Neogen
NEOG
2.33-85.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
11.7-25.24%๐Ÿ‡บ๐Ÿ‡ธ USA